Fasenra subcutaneous injection 10mg syringe (YJ code: 2290402G2027, standard: 10mg 0.5mL x 1 tube) is an AstraZeneca medication containing Benralizumab (genetical recombination). It is indicated for severe eosinophilic asthma, with a 10mg dose typically used for children aged 6-11 years who weigh less than 35 kg.
Fasenra subcutaneous injection 10mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).